Augmentation of pharmacotherapy by sleep deprivation with sleep phase advance in treatment-resistant depression: Changes of cortisol, IL-10, and IL-1β

被引：0
|
作者：
Dopierala, E. [1 ]
Ferensztajn-Rochowiak, E. [1 ]
Jasinska-Mikolajczyk, A. [1 ]
Chlopocka-Wozniak, M. [1 ]
Rybakowski, J. [1 ,2 ]
机构：
[1] Poznan Univ Med Sci, Dept Adult Psychiat, Poznan, Poland
[2] Poznan Univ Med Sci, Dept Child & Adolescent Psychiat, Poznan, Poland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2018.11.588
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.574
引用
收藏
页码：S386 / S386
页数：1
相关论文
共 45 条
  • [1] Augmentation of Pharmacotherapy by Sleep Deprivation with Sleep Phase Advance in Treatment-Resistant Depression
    Kurczewska, Ewa
    Ferensztajn-Rochowiak, Ewa
    Jasinska-Mikolajczyk, Anna
    Chlopocka-Wozniak, Maria
    Rybakowski, Janusz K.
    [J]. PHARMACOPSYCHIATRY, 2019, 52 (04) : 186 - 192
  • [2] Treatment-resistant depression: Neurobiological correlates and the effect of sleep deprivation with sleep phase advance for the augmentation of pharmacotherapy
    Kurczewska, Ewa
    Ferensztajn-Rochowiak, Ewa
    Rybakowski, Filip
    Michalak, Michal
    Rybakowski, Janusz
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2021, 22 (01): : 58 - 69
  • [3] Sleep deprivation with sleep phase advance as augmentation of pharmacotherapy in treatment-resistant depression: biochemical correlates of response
    Kurczewska, E.
    Chlopocka-Wozniak, M.
    Rybakowski, J.
    [J]. EUROPEAN PSYCHIATRY, 2019, 56 : S594 - S594
  • [4] Sleep deprivation with sleep phase advance in treatment-resistant depression: biological features of efficacy
    Dopierala, E.
    Jasinska-Mikolajczyk, A.
    Ferensztajn-Rochowiak, E.
    Chlopocka-Wozniak, M.
    Rybakowski, J. K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S848 - S849
  • [5] Total sleep deprivation with sleep phase advance in treatment-resistant depression: Correlates of clinical response
    Kurczewska, E.
    Chlopocka-Wozniak, M.
    Rybakowski, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S694 - S695
  • [6] Factors connected with the efficacy of total sleep deprivation with sleep phase advance in treatment-resistant depression
    Dopierala, E.
    Ferensztajn-Rochowiak, E.
    Chlopocka-Wozniak, M.
    Jaracz, J.
    Rybakowski, J. K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S462 - S462
  • [7] Treatment of depression with a combination of sleep deprivation with consecutive sleep phase advance
    Hohagen, F
    Konig, A
    Riemann, D
    Edali, N
    Faller, C
    Voderholzer, U
    Berger, M
    [J]. NERVENHEILKUNDE, 1995, 14 (08) : 422 - 428
  • [8] The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion
    Borowska, Magdalena
    Dworacka, Marzena
    Wesolowska, Anna
    Winiarska, Hanna
    Krzyzagorska, Ewa
    Dworacki, Grzegorz
    [J]. PHARMACOLOGY, 2016, 97 (3-4) : 189 - 194
  • [9] Effective Antidepressant Chronotherapeutics (Sleep Deprivation and Light Therapy) Normalize the IL-1β:IL-1ra Ratio in Bipolar Depression
    Benedetti, Francesco
    Dallaspezia, Sara
    Melloni, Elisa Maria Teresa
    Lorenzi, Cristina
    Zanardi, Raffaella
    Barbini, Barbara
    Colombo, Cristina
    [J]. FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [10] Changes in the Serum Levels of Cytokines: IL-1β, IL-4, IL-8 and IL-10 in Depression with and without Posttraumatic Stress Disorder
    Oglodek, Ewa
    [J]. BRAIN SCIENCES, 2022, 12 (03)
12345